Peginterferon alfa-2a
Based on 1 Customer Validation
Peginterferon alfa-2a (Ro 25-8310/000) is a 40 kDa branched pegylated IFN alfa-2a with antiviral and immunomodulatory activities. Peginterferon alfa-2a binds to the Interferon Receptor on the surface of target cells, induces the formation of ISGF3, and promotes the expression of effector proteins such as interferon-stimulated genes (ISGs) and Mx proteins, thereby exerting sustained antiviral effects. Peginterferon alfa-2a is applicable to research on virus infections associated with chronic hepatitis C and chronic hepatitis B.
For research use only. We do not sell to patients.
- CAS No.: 198153-51-4
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Conjugated
Conjugated with pegol
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Chemical Information
-
CAS No. 198153-51-4
-
Appearance Liquid
-
Color Colorless to light yellow
-
SMILES
[Peginterferon alfa-2a]
-
Synonyms
Ro 25-8310/000
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (270 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
[1]. Matthews SJ, et al. Peginterferon alfa-2a: a review of approved and investigational uses. Clinical therapeutics. 2004 Jul;26(7):991-1025. [Content Brief]
[2]. Rajender Reddy K, et al. Use of peginterferon alfa-2a (40 KD) (Pegasys) for the treatment of hepatitis C. Advanced drug delivery reviews. 2002 Jun 17;54(4):571-86. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Peginterferon alfa-2a Related Classifications
HY-108839 Related Classifications
Powered by Bioz
Keywords
- Peginterferon alfa-2a
- 198153-51-4
- Ro 25-8310/000
- IFNAR
- IFN-stimulated gene products
- IFN-stimulated gene factor 3
- chronic myelogenous leukemia
- chronic hepatitis C virus infection
- IFN-stimulated response elements
- advanced renal cell carcinoma
- HCV-specific CD4+ Th1 response
- liver tissue
- metastatic malignant melanoma
- chronic hepatitis B infection
- Inhibitor
- inhibitor
- inhibit